Literature DB >> 12468497

CONSORT statement requires closer examination.

Douglas G Altman, Kenneth F Schulz, David Moher.   

Abstract

Mesh：

Year:  2002        PMID： 12468497      PMCID： PMC1124816          DOI： 10.1136/bmj.325.7376.1364/a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

2.  Interpreting the number needed to treat.

Authors:  Kenneth F Schulz; David Moher; Douglas G Altman
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

3.  Preventing stroke with ramipril. Results should have been presented in ways that help practising clinicians.

Authors:  P Badrinath
Journal:  BMJ       Date:  2002-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.